Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability
Thi‐Thao‐Linh Nguyen, Van‐An Duong, Han‐Joo Maeng
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1103-1103
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 897-897
Open Access | Times Cited: 74
Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 572-572
Open Access | Times Cited: 71
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Van‐An Duong, Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 207-207
Open Access | Times Cited: 57
Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
Jihoon Lee, Min‐Koo Choi, Im‐Sook Song
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 802-802
Open Access | Times Cited: 48
Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review
Dhvani Patel, Nutan Sethi, Paresh Patel, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 198, pp. 114267-114267
Closed Access | Times Cited: 14
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, R. Nagarajan
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 40
Enhanced anticancer activity of encapsulated geraniol into biocompatible lipid nanoparticles against A549 human lung cancer cells
Boris Rodenak‐Kladniew, Rocío Celeste Gambaro, José Sebastián Cisneros, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104159-104159
Closed Access | Times Cited: 23
Chitosan in Oral Drug Delivery Formulations: A Review
Tanikan Sangnim, Divya Dheer, Nitin Jangra, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2361-2361
Open Access | Times Cited: 23
Recent progress in tannic acid based approaches as a natural polyphenolic biomaterial for cancer therapy: A review
Motaleb Ghasemian, Fahimeh Kazeminava, Ashkan Naseri, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115328-115328
Open Access | Times Cited: 21
GC–MS analysis, molecular docking, and pharmacokinetic studies of Multidentia crassa extracts’ compounds for analgesic and anti-inflammatory activities in dentistry
Ibrahim Chikowe, King David Bwaila, Samuel Chima Ugbaja, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Solubilization techniques used for poorly water-soluble drugs
Bing Xie, Yaping Liu, Xiaotong Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4683-4716
Open Access | Times Cited: 9
Sustained release polymer and surfactant based solid dispersion of andrographolide exhibited improved solubility, dissolution, pharmacokinetics, and pharmacological activity
Syed Assim Haq, Gourav Paudwal, Nagma Banjare, et al.
International Journal of Pharmaceutics (2024) Vol. 651, pp. 123786-123786
Closed Access | Times Cited: 7
Co-release of paclitaxel and encequidar from amorphous solid dispersions increase oral paclitaxel bioavailability in rats
Emilie Fynbo Petersen, Bjarke Strøm Larsen, Rasmus Blaaholm Nielsen, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123965-123965
Open Access | Times Cited: 7
Cutting-edge development in dendritic polymeric materials for biomedical and energy applications
Mohammad R. Thalji, Amal Amin, Gomaa A. M. Ali
European Polymer Journal (2021) Vol. 160, pp. 110770-110770
Closed Access | Times Cited: 42
Approaches to minimize the effects of P‐glycoprotein in drug transport: A review
Athar Husain, Vishal Makadia, Guru R. Valicherla, et al.
Drug Development Research (2022) Vol. 83, Iss. 4, pp. 825-841
Closed Access | Times Cited: 30
Solid Lipid Nanoparticles
Thi‐Thao‐Linh Nguyen, Van‐An Duong
Encyclopedia (2022) Vol. 2, Iss. 2, pp. 952-973
Open Access | Times Cited: 29
Cytotoxic Screening and Enhanced Anticancer Activity of Lippia alba and Clinopodium nepeta Essential Oils-Loaded Biocompatible Lipid Nanoparticles against Lung and Colon Cancer Cells
Boris Rodenak‐Kladniew, María Agustina Castro, Rocío Celeste Gambaro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2045-2045
Open Access | Times Cited: 19
Pharmaceutical polymers and P-glycoprotein: Current trends and possible outcomes in drug delivery
Mohamed S. Attia, Mohamed T. Elsebaey, Galal Yahya, et al.
Materials Today Communications (2023) Vol. 34, pp. 105318-105318
Closed Access | Times Cited: 17
Exploratory studies on chrysin via antioxidant, antimicrobial, ADMET, PASS and molecular docking evaluations
Adedotun F. Adesina, Adewale Adewuyi, Chiagoziem A. Otuechere
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 11, pp. 100413-100413
Open Access | Times Cited: 6
Regulation of P-Glycoprotein during Oxidative Stress
A. V. Shchulkin, Yu. V. Abalenikhina, O. V. Kosmachevskaya, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 215-215
Open Access | Times Cited: 5
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Hyeonji Yoo, Yeon-Jin Kim, Jinseong Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 3994-3994
Open Access | Times Cited: 5
VIRTUAL SCREENING AND PREDICTION OF ADME PERAMETERS OF A SERIES OF 5-ARYLIDENE SUBSTITUTED DERIVATIVES OF RHODANINE WITH BENZOTHIAZOLE MOIETY IN THE MOLECULES
Л. М. Мосула, В. С. Мосула
Art of Medicine (2025), pp. 60-65
Closed Access
Comparison of new secondgeneration H1 receptor blockers with some molecules; a study involving DFT, molecular docking, ADMET, biological target and activity
Velid Ünsal, Erkan Öner, Reşit Yıldız, et al.
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Computational modeling design of novel NMDAR agonist for the treatment of Schizophrenia
Amena Khatun Manica, Maria Daud, Michael Olanrewaju Faloyo, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top